NCT03003975 Single Versus Double Cryoballoon Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation Status COMPLETED Phase NA
NCT02998905 NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH Status COMPLETED Phase PHASE2
NCT02997254 COMparison of Physiological Algorithms for Real-time Evaluation of Atrial Fibrillation Status RECRUITING Phase N/A
NCT02996435 Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation Status COMPLETED Phase PHASE4
NCT02987062 MultiCenter expeRience in AFib Patients Treated With OAC (CRAFT) Status UNKNOWN Phase N/A
NCT02982850 Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease Status COMPLETED Phase PHASE4
NCT02982434 The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation Status UNKNOWN Phase PHASE2
NCT02975453 Study of Major Cardiovascular Events in Patients With Nonvalvular Atrial Fibrillation Treated With Rivaroxaban Status COMPLETED Phase N/A
NCT02973984 The European Registry of Older Subjects With Atrial Fibrillation (EUROSAF) Status UNKNOWN Phase N/A
NCT02964949 Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes Status COMPLETED Phase NA
NCT02964546 Glomerular Filtration Rate-Estimating Equations During Use of Direct Oral Anticoagulants in Elderly Patients Status TERMINATED Phase N/A